stock-detail (OHRP)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/18/2017 06:18 am

4/18/2017 06:18 am

4/18/2017 06:18 am

4/18/2017 06:18 am

4/11/2017 12:17 pm

4/11/2017 12:17 pm

4/11/2017 12:17 pm

4/11/2017 12:17 pm

4/10/2017 12:17 pm

Ohr Pharmaceutical to Present at the Cowen & Company 37th Annual Health Care Conference

3/2/2017 02:03 pm

[GlobeNewswire] - NEW YORK, March 02, 2017-- Ohr Pharmaceutical, Inc., a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that Jason Slakter, MD, Chief Executive ...

Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings

2/14/2017 12:00 pm

[GlobeNewswire] - Management to Host a Conference Call and Webcast at 7:45a.m Eastern Time Today. NEW YORK, Feb. 14, 2017-- Ohr Pharmaceutical, Inc., a clinical-stage pharmaceutical company developing novel therapies for ...

Ohr Pharmaceutical to Announce First Quarter 2017 Financial Results on February 14

2/13/2017 03:03 pm

[GlobeNewswire] - NEW YORK, Feb. 13, 2017-- Ohr Pharmaceutical, Inc., an ophthalmology research and development company, today announced that it will report financial results for its first fiscal quarter ended December ...

Post Earnings Coverage as Ohr Pharma Reported Annual Results; Announced Closure of Public Offering

1/5/2017 01:01 pm

[Accesswire] - Upcoming AWS Coverage on Seattle Genetics Post-Earnings Results LONDON, UK / ACCESSWIRE / January 5, 2017 / Active Wall St. announces its post-earnings coverage on Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ...